We're hiring! We are excited to be in our new home @VCU in Richmond, VA and are actively recruiting lab members at all levels! If you're interested in basic or translational science in dystrophic muscle 💪 or heart ❤️, contact us!
Happy to share our latest article: Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping: Molecular Therapy - Nucleic Acids https://t.co/I9S1nAHH4B. Congrats to first author and talented post-doc @nikkimmccormack! #DMD#microRNA (1/3)
Great First Person author interview with Trinitee! Thank you for the great journal experience, and for highlighting promising young scientists @DMM_Journal
https://t.co/ezU7je8xHn
The recent @fda approval of the #MDA-Supported Drug AGAMREE® (vamorolone) from @catalystforrare is a beacon of hope for people living with #Duchenne#MuscularDystrophy (#DMD), a rare but serious degenerative muscle disease. Learn more in #Quest: https://t.co/xSG8r61YUw
Today, the U.S. Food and Drug Administration (FDA) has granted its approval for Vamorolone, a new treatment for Duchenne Muscular Dystrophy (DMD) aged 2 years and older.
https://t.co/z1l0vy0NRk
Positive news for boys with #Becker#MuscularDystrophy: Vamorolone improves disease progression with fewer side effects than current treatments. Read more from @TheHeierLab, @AlysonAFiorillo & the Center for Genetic Medicine Research. ⬇️ https://t.co/W17hjommbK
Pleased to announce that the PDF file of our article on DG9-conjugated #morpholino and rescue in #SMA mice is now available @JCI_insight. This promising delivery strategy reached the CNS via an SC administration. https://t.co/BFI16K6DDd @UAlberta_FoMD supported by @WCHRIUofA
Happy to share out latest methods paper on: Comprehensive Analyses of Muscle Function, Lean and Muscle Mass, and Myofiber Typing in Mice https://t.co/h5rgeEHB7d
Thrilled to share our latest findings on the potential of DG9-conjugated morpholino as a treatment for spinal muscular atrophy! Our study shows significant improvements in survival, SMN expression, and muscle function in a mouse model. @UAlberta_FoMD https://t.co/gAkfsar3Kr
Investigators at the Center for Genetic Medicine Research @AlysonAFiorillo & @MacGyver0282 created a model to test new treatments for Becker muscular dystrophy, providing hope to the growing number of patients with this debilitating neuromuscular disease. https://t.co/KFq37WqiFx
Only two weeks (and two days) to our first Circadian Biology Workshop at Cincinnati Children's - University of Cincinnati. Looking forward to new data, exciting new ideas and new collaborations in the making @CincyChildrens @CincyKidsOAACD @uofcincy
A huge round of applause 👏🏽 for the newly-minted Dr. Kelly Murphy, who has defended her dissertation investigating antisense oligonucleotide (AON) therapy for facioscapulohumeral #MuscularDystrophy (FSHD) in the Chen lab! 🎉💪🏽 #GWIBSFamily#DissertationProps#WomenInSTEM#PhDLife
Our lab is hiring postdocs to study muscle and heart function and disease through the perspectives of circadian, metabolic and epigenetic mechanisms. Our lab is committed to diversity, equity and inclusion and supports all career aspirations @CCHMCPostdoc